Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Four things for CMS to keep in mind as they implement changes to Part D

By Nicole Longo  |    June 7, 2023
The Inflation Reduction Act (IRA) makes significant changes to Part D’s benefit structure and coverage, which will require careful policy development and thoughtful implementation. On Monday, PhRMA...   Read More

Addressing Mental Health: A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    May 30, 2023
As we recognize Mental Health Awareness Month, I had the opportunity to connect with PhRMA board member Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address mental health.     Read More

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

By Andrew Powaleny  |    May 11, 2023
America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...   Read More

Support for continued progress is critical for pediatric drug development

By Abigail Lore  |    May 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...   Read More

New resource underscores the importance of small molecule medicines

By Lindsey Seidlitz  |    May 4, 2023
A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines...   Read More

CMS guidance on IRA price setting process doubles down on bad policy

By Nicole Longo  |    April 14, 2023
As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The...   Read More

New global analysis shows patient access challenges around the world

By Richard Kane  |    April 12, 2023
Today PhRMA released a new report that analyzes the share of new medicines that are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines...   Read More

ICYMI: PhRMA President and CEO Stephen J. Ubl discusses patient affordability

By Emilie Signora  |    April 7, 2023
PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’s event, “Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re...   Read More

New Report: More than 400 medicines in development for leading chronic conditions affecting older Americans

By Lucy Vereshchagina  |    March 28, 2023
Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and...   Read More

Celebrating the success of the COVID-19 vaccines, and looking to the future

By Michael Ybarra  |    March 27, 2023
It’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates